Comment on Savioli et al. Mild Head Trauma: Is Antiplatelet Therapy a Risk Factor for Hemorrhagic Complications?
Medicina
2021,
57
, 357
Medicina (Kaunas)
.
2021 Aug 27;57(9):887.
doi: 10.3390/medicina57090887.
Authors
Bartolomeo Lorenzati
1
,
Alice Bruno
2
,
Giulia Racca
3
,
Jacopo Giamello
4
,
Attilio Allione
1
,
Letizia Barutta
1
,
Emanuele Bernardi
1
,
Ilaria Blangetti
5
,
Alessia Bono
1
,
Luca Dutto
1
,
Chiara Fulcheri
1
,
Remo Galaverna
6
,
Alberto Grosso
1
,
Elena Maggio
1
,
Gianpiero Martini
1
,
Vincenzo Peloponneso
1
,
Massimo Perotto
7
,
Tania Prinzis
1
,
Paola Ramonda
6
,
Alessandro Raviolo
1
,
Massimo Rega
1
,
Andrea Tortore
1
,
Francesco Tosello
1
,
Andrea Sciolla
1
,
Giuseppe Lauria
1
,
On Behalf Of Trauma Management Course Faculty
Affiliations
1
Emergency Medicine, Department of Emergency and Critical Care, A.O. S. Croce e Carle Hospital, 12100 Cuneo, Italy.
2
School of Emergency Medicine, University of Pavia, 27100 Pavia, Italy.
3
Internal Medicine, Department of Medicine, A.O. S. Croce e Carle Hospital, 12100 Cuneo, Italy.
4
School of Emergency Medicine, University of Turin, 10100 Turin, Italy.
5
Intensive Care Unit, Regina Montis Regalis Hospital, 12084 Mondovi, Italy.
6
Intensive Care Unit, Department of Emergency and Critical Care, A.O. S. Croce e Carle Hospital, 12100 Cuneo, Italy.
7
Internal Medicine, Department of Medicine, P.O. Michele Ferrero Hospital, 12060 Verduno, Italy.
PMID:
34577810
PMCID:
PMC8470498
DOI:
10.3390/medicina57090887
Abstract
We read the article of Savioli G. et al. [...].
MeSH terms
Craniocerebral Trauma* / complications
Humans
Platelet Aggregation Inhibitors* / adverse effects
Retrospective Studies
Risk Factors
Substances
Platelet Aggregation Inhibitors